Real-world outcomes of treatment with insulin glargine 300 U/mL versus standard-of-care in people with uncontrolled type 2 diabetes mellitus
-
Freemantle, Nick (University College London)
;
Mauricio Puente, Dídac (Institut d'Investigació Biomèdica Sant Pau) ;
Giaccari, Andrea (Università Cattolica del Sacro Cuore) ;
Bailey, Timothy (AMCR Institute) ;
Roussel, Ronan (UFR de Médecine. Paris University) ;
Franco, Denise (CPCLIN Clinical Research Center) ;
Berthou, Baptiste (IT&M Stats) ;
Pilorget, Valerie (Sanofi) ;
Westerbacka, Jukka (Sanofi) ;
Bosnyak, Zsolt (Sanofi) ;
Bonnemaire, Mireille (Sanofi) ;
Cali, Anna M.G (Sanofi) ;
Nguyên-Pascal, My-Liên (Sanofi) ;
Penfornis, Alfred (Corbeil-Essonnes and Université Paris Sud) ;
Perez-Maraver, Manuel (Hospital Universitari de Bellvitge) ;
Seufert, Jochen (University of Freiburg) ;
Sullivan, Sean D. (University of Washington) ;
Wilding, John (University of Liverpool) ;
Wysham, Carol (Multicare Rockwood Clinic) ;
Davies, Melanie (University of Leicester) ;
Universitat Autònoma de Barcelona
visitante ::
identificación
Subscribirse to this discussion. You will then receive all new comments by email.
